Results 151 to 160 of about 170,341 (384)

MBA-Net: SAM-driven Bidirectional Aggregation Network for Ovarian Tumor Segmentation [PDF]

arXiv
Accurate segmentation of ovarian tumors from medical images is crucial for early diagnosis, treatment planning, and patient management. However, the diverse morphological characteristics and heterogeneous appearances of ovarian tumors pose significant challenges to automated segmentation methods.
arxiv  

“Therapies Through Gut:” Targeted Drug Delivery for Non‐Gastrointestinal Diseases by Oral Administration

Advanced Healthcare Materials, EarlyView.
Schematic illustration of the mechanism of targeted delivery of nanoparticles including 1) paracellular, 2) endolysosomal escape, 3) receptor mediated endocytosis, and 4) M cell mediated transport for non‐GI diseases by oral administration such as atherosclerosis, cancer, diabetes, and brain diseases. Abstract Oral drug delivery is a promising approach
Subarna Ray, Shehzahdi S. Moonshi, Hang Thu Ta   +2 more
wiley   +1 more source

Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas

Molecular Cancer, 2009
Background DNA repair genes critically regulate the cellular response to chemotherapy and epigenetic regulation of these genes may be influenced by chemotherapy exposure.
Walsh Tom, Garcia Rochelle L, Taniguchi Toshiyasu, Gonzalez Rachel M, Swisher Elizabeth M, Goff Barbara A, Welcsh Piri   +6 more
doaj   +1 more source

The Histopathological Patterns of Ovarian Neoplasms in Different Age Groups: A Retrospective Study in a Tertiary Care Center. [PDF]

Cureus, 2022
Farag NH, Alsaggaf ZH, Bamardouf NO, Khesfaty DM, Fatani MM, Alghamdi MK, Saharti SN.   +6 more
europepmc   +1 more source

Second neoplasms and ovarian cancer

, 2011
Recent studies have suggested that different histological types of ovarian cancer develop via different pathways. Large epidemiological studies of first and second malignant neoplasms associated with ovarian cancer can quantify such risk and may provide etiologic clues in understanding these complex[for full text, please go to the a.m. URL]
Marron, M, Blettner, M, Zeeb, H, Scélo, G, Hemminki, K, Olsen, JH, Pukkala, E, Weiderpass, E, Tracey, E, Brewster, DH, Tamaro, S, Pompe-Kirn, V, Kliewer, EV, Chia, KS, Tonita, JM, Martos, C, Jonasson, JG, Ohgaki, H, Brennan, P, Boffetta, P, The Tisch Cancer Institute, Mount Sinai School of Medicine, New York, USA   +20 more
openaire   +1 more source

Expression of the HER-2/neu proto-oncogene in serous ovarian neoplasms [PDF]

, 1992
Jeffrey D. Seidman, Dennis M. Frisman, Henry J. Norris   +2 more
openalex   +1 more source

Longer Acting Injectable: Continuous, Linear Release of a Progestin Contraceptive From an Oxidized Porous Silicon Host

Advanced Healthcare Materials, EarlyView.
Progestin drugs are loaded into a mesoporous silicon dioxide host by melt‐infiltration. Drugs that decompose at or close to their melting point can be loaded by the addition of cholesterol, which acts as a melting point suppressor. High mass loading of the drug is achieved, and dissolution of the composite is controlled by the nanoscale properties of ...
Geoffrey Hollett, Ruhan Fan, Tushar Kumeria, Heidi Leonard, Byungji Kim, Taylor R. Martin, Irmak Ipekci, Joanna Wang, Jiuk Byun, Nicole A. Chan, Amber Pierron, Curtis E. Moore, Jennifer Ayres, Michael J. Sailor   +13 more
wiley   +1 more source

A Case Report of Pseudomyxoma Peritonei Arising From Primary Mucinous Ovarian Neoplasms. [PDF]

Cureus, 2022
Joseph R, Sathiamoorthy R, Gnanasekaran R, Gunasekaran L, Ilangovan G.   +4 more
europepmc   +1 more source

Bilateral serous cystadenofibroma of ovary with paratubal cyst: a rare case report [PDF]

, 2017
Ovarian cystadenofibromas comprise very rare group of ovarian neoplasms with mixture of epithelial and fibrous stromal components. Here we present a case of a postmenopausal female who had bilateral ovarian cystadenofibromas along with a paratubal ...
Aghav, Bhagitra, Gadekar, Shruti, Katke, Rajshree Dayanand, Shaikh, Asheq   +3 more
core   +1 more source

Benchmarking Histopathology Foundation Models for Ovarian Cancer Bevacizumab Treatment Response Prediction from Whole Slide Images [PDF]

arXiv
Bevacizumab is a widely studied targeted therapeutic drug used in conjunction with standard chemotherapy for the treatment of recurrent ovarian cancer. While its administration has shown to increase the progression-free survival (PFS) in patients with advanced stage ovarian cancer, the lack of identifiable biomarkers for predicting patient response has
arxiv